Shock wave therapy market to reach $3.62 billion by 2030

The Business Research Company says the global shock wave therapy market is set to grow from $2.03 billion in 2025 to $3.62 billion by 2030, driven by rising musculoskeletal disease, sports injuries and demand for non-invasive pain treatment. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Shock wave therapy is gaining traction as a non-invasive option for pain relief and musculoskeletal care. - The market’s projected growth signals more demand for outpatient treatment, rehabilitation services and orthopedic devices. - Rising musculoskeletal disease rates are expanding the patient pool that could use this therapy.

What happened: - The Business Research Company released a 2026 report on the global shock wave therapy market. - The report estimates the market will grow from $2.03 billion in 2025 to $2.28 billion in 2026. - The report projects the market will reach $3.62 billion by 2030. - The report cites a 12.5% CAGR for the historical growth period and 12.2% CAGR for the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing region. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report sample is available here. - The full report is available here.

The details: - Shock wave therapy uses high-energy acoustic waves to help heal damaged or inflamed tissue. - The treatment works by stimulating blood flow, accelerating tissue regeneration and breaking down calcified deposits. - Common uses include musculoskeletal conditions, chronic pain syndromes and tendon disorders. - The report links historical growth to rising musculoskeletal disorders, wider use in sports medicine, clinical acceptance, more chronic pain cases and expanded hospital rehabilitation programs. - The report links forecast growth to more physiotherapy centers, an aging population, more sports-related injuries, device innovation and more outpatient therapy services. - Forecast trends include non-invasive pain management, enhanced sports injury rehabilitation, growth in orthopedic therapies, multi-functional shock wave equipment and more clinic-based use. - The report also highlights new 2026 features including market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The UK Office for Health Improvement and Disparities reported in January 2024 that 18.4% of people age 16 and older had a long-term musculoskeletal condition in 2023, up from 17.6% in 2022. - The same UK data showed higher prevalence among females at 20.9% versus 15.8% for males.

Between the lines: - The report frames shock wave therapy as part of a broader shift toward less invasive treatment options in pain management and rehabilitation. - The strongest near-term opportunity appears to be in clinics and outpatient settings, where convenience and repeat treatment can matter more. - Regional growth divergence suggests mature markets may rely on adoption depth, while emerging markets may benefit from broader access and equipment expansion.

What's next: - The market’s next phase will likely be shaped by device innovation, clinic adoption and broader use in orthopedic and rehabilitation care. - Growth in Asia-Pacific could narrow the gap with North America if outpatient services and physiotherapy infrastructure continue expanding. - Increasing musculoskeletal disease prevalence is likely to keep demand elevated through the rest of the decade.

The bottom line: - Shock wave therapy is moving from a niche treatment to a faster-growing segment in non-invasive pain and rehabilitation care.